Biotechs Pressured Following Clinton Tweet (IBB)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St futures rise as Fed rate hike lifts long-standing overhang
- Oil slips as Saudi Arabia offers more crude via Oman
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Exclusive-SK Hynix in talks with Intel about deal to make memory chips in US for the first time, sources say
- Trade the FOMC: How stocks tend to perform on Fed hike days
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
Hillary Clinton Tweet Doesn't Change Bullish View on Valeant Pharmaceuticals (VRX), BMO Capital Says
September 21, 2015 1:57 PM EDTBMO Capital analyst Alex Arfaei weighed in on Valeant Pharmaceuticals (NYSE: VRX) which is down 6% in response to a Tweet from Hillary Clinton referring to this article in the... More
UPDATE: Biotech Bounces Off Lows (IBB)
September 21, 2015 1:19 PM EDT(Updated - September 21, 2015 1:29 PM EDT)
Biotech stocks bounced off lows Monday afternoon, paring declines that were largely driven by fears of increased government regulation of drug pricing. The source of concern was a tweet by presidential candidate Hillary Clinton... More
Cowen Remains Bullish on Gilead Sciences (GILD) Following Data Release
September 21, 2015 1:13 PM EDTCowen reiterated an Outperform rating and $125.00 price target on Gilead Sciences (NASDAQ: GILD) following the release top-line data from the Ph. III ASTRAL trials of SOF+VEL.
Analyst Phil Nadeau commented, "GILD released top-line data from the Ph. III ASTRAL trials of... More
